Lactoferrin is associated with a decrease in oocyte depletion in mice receiving cyclophosphamide

Fertility and Sterility

Volumn 91, Issue 5 SUPPL., 2009, Pages

  Horiuchi, Yuka ^a   Higuchi, Toshihiro ^a   Tatsumi, Keiji ^a   Takakura, Kenji ^a   Fujii, Shingo ^b   Konishi, Ikuo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Cyclophosphamide; fertility preservation; lactoferrin; premature ovarian failure

Indexed keywords

ADAM PROTEIN; ADAMTS1 PROTEIN; BETA ACTIN; CASPASE 2; CYCLINE; CYCLOPHOSPHAMIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GUANYLATE CYCLASE ACTIVATOR; LACTOFERRIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; OSTEOPONTIN; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ADAMTS1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FERTILITY; GENE; GENE EXPRESSION; GENE FUNCTION; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; MOUSE; NONHUMAN; OVULATION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SOHLH1 GENE; STATISTICAL ANALYSIS;

EID: 65049084167     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.024     Document Type: Article

References (33)

1. Warne G.L., Fairley K.F., Hobbs J.B., and Martin F.I. Cyclophosphamide-induced ovarian failure. N Eng J Med 289 (1973) 1159-1162
2. Watson A.R., Taylor J., Rance C.P., and Bain J. Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study. Fertil Steril 46 (1986) 331-333
3. Falcone T., Attaran M., Bedaiwy M.A., and Goldberg J.M. Ovarian function preservation in the cancer patient. Fertil Steril 81 (2004) 243-257
4. Donnez J., Dolmans M.M., Demylle D., Jadoul P., Pirard C., Squifflet J., et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364 (2004) 1405-1410
5. Meirow D., Hardan I., Dor J., Fridman E., Elizur S., Ra'anani H., et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23 (2008) 1007-1013
6. Somers E.C., Marder W., Christman G.M., Ognenovski V., and McCune W.J. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus. Arthritis Rheum 52 (2005) 2761-2767
7. Blumenfeld Z., Avivi I., Eckman A., Epelbaum R., Rowe J.M., and Dann E.J. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89 (2008) 166-173
8. Meirow D., Assad G., Dor J., and Rabinovici J. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice. Hum Reprod 19 (2004) 1294-1299
9. Danforth D.R., Arbogast L.K., and Friedman C.I. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists. Fertil Steril 83 (2005) 1333-1338
10. Morita Y., Perez G.I., Paris F., Miranda S.R., Ehleiter D., Haimovitz-Friedman A., et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med 6 (2000) 1109-1114
11. Hancke K., Strauch O., Kissel C., Göbel H., Schäfer W., and Denschlag D. Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo. Fertil Steril 87 (2007) 172-177
12. Hu X., Roberts J.R., Apopa P.L., Kan Y.W., and Ma Q. Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice. Mol Cell Biol 26 (2006) 940-954
13. Bergeron L., Perez G.I., Macdonald G., Shi L., Sun Y., Jurisicova A., et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 12 (1998) 1304-1314
14. Espey L.L. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 50 (1994) 233-238
15. Shozu M., Minami N., Yokoyama H., Inoue M., Kurihara H., Matsushima K., et al. Adamts-1 is involved in normal follicular development, ovulatory process and organization of the medullary vascular network in the ovary. J Mol Endocrinol 35 (2005) 343-355
16. Pangas S.A., Choi Y., Ballow D.J., Zhao Y., Westphal H., Matzuk M.M., et al. Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. Proc Natl Acad Sci U S A 103 (2006) 8090-8095
17. Kanyshkova T.G., Buneva V.N., and Nevinsky G.A. Lactoferrin and its biological functions. Biochemistry (Mosc) 66 (2001) 1-7
18. Pangas S.A., Rademaker A.W., Fishman D.A., and Woodruff T.K. Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J Clin Endocrinol Metab 87 (2002) 2644-2657
19. Muskhelishvili L., Wingard S.K., and Latendresse J.R. Proliferating cell nuclear antigen-a marker for ovarian follicle counts. Toxicol Pathol 33 (2005) 365-368
20. Myers M., Britt K.L., Wreford N.G., Ebling F.J., and Kerr J.B. Methods for quantifying follicular numbers within the mouse ovary. Reproduction 127 (2004) 569-580
21. Buhaescu I., Covic A., and Deray G. Treatment of proliferative lupus nephritis-a critical approach. Semin Arthritis Rheum 36 (2007) 224-237
22. Reddy P., Shen L., Ren C., Boman K., Lundin E., Ottander U., et al. Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol 281 (2005) 160-170
23. Richards J.S., Sharma S.C., Falender A.E., and Lo Y.H. Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol Endocrinol 16 (2002) 580-599
24. Shukovski L., and Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 135 (1994) 2287-2290
25. Espey L.L., Yoshioka S., Russell D.L., Robker R.L., Fujii S., and Richards J.S. Ovarian expression of a disintegrin and metalloproteinase with thrombospondin motifs during ovulation in the gonadotropin-primed immature rat. Biol Reprod 62 (2000) 1090-1095
26. Simbulan-Rosenthal C.M., Trabosh V., Velarde A., Chou F.P., Daher A., Tenzin F., et al. Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation. Oncogene 24 (2005) 5443-5458
27. Claeskens A., Ongenae N., Neefs J.M., Cheyns P., Kaijen P., Cools M., et al. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer 82 (2000) 1123-1130
28. Shoji H., Oguchi S., Shinohara K., Shimizu T., and Yamashiro Y. Effects of iron-unsaturated human lactoferrin on hydrogen peroxide-induced oxidative damage in intestinal epithelial cells. Pediatr Res 61 (2007) 89-92
29. Fujita K., Matsuda E., Sekine K., Iigo M., and Tsuda H. Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25 (2004) 1961-1966
30. Varadhachary A., Wolf J.S., Petrak K., O'Malley Jr. B.W., Spadaro M., Curcio C., et al. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 111 (2004) 398-403
31. Walmer D.K., Wrona M.A., Hughes C.L., and Nelson K.G. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology 131 (1992) 1458-1466
32. Yanaihara A., Mitsukawa K., Iwasaki S., Otsuki K., Kawamura T., and Okai T. High concentrations of lactoferrin in the follicular fluid correlate with embryo quality during in vitro fertilization cycles. Fertil Steril 87 (2007) 279-282
33. Suzuki Y.A., and Lönnerdal B. Baculovirus expression of mouse lactoferrin receptor and tissue distribution in the mouse. Biometals 17 (2004) 301-309